Open AccessThe efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
Author(s) -
Mert Şimşek,
Mehmet Çıtırık,
Serdar Özateş,
Dilara Özkoyuncu
Publication year - 2018
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_1259_17
Subject(s) - medicine , macular edema , central retinal vein occlusion , retinal vein , ophthalmology , intraocular pressure , fluorescein angiography , visual acuity , dexamethasone , occlusion , surgery
This study evaluated the effect of intravitreal dexamethasone implant (IDI; Ozurdex) injection for treating macular edema in patients with branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).